DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

29.03B

Market cap29.03B

Price-Earnings ratio

31.98

Price-Earnings ratio31.98

Dividend yield

—

Dividend yield—

Average volume

5.91M

Average volume5.91M

High today

$76.03

High today$76.03

Low today

$74.04

Low today$74.04

Open price

$74.65

Open price$74.65

Volume

6.56M

Volume6.56M

52 Week high

$89.98

52 Week high$89.98

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

As of today, DexCom(DXCM) shares are valued at $74.34. The company's market cap stands at 29.03B, with a P/E ratio of 31.98.

As of 2026-06-12, DexCom(DXCM) stock has fluctuated between $74.04 and $76.03. The current price stands at $74.34, placing the stock +0.4% above today's low and -2.2% off the high.

The DexCom(DXCM)'s current trading volume is 6.56M, compared to an average daily volume of 5.91M.

In the last year, DexCom(DXCM) shares hit a 52-week high of $89.98 and a 52-week low of $54.11.

DXCM News

Investing.com 12h

Pharmsource says it was unaware Dexcom sensors were stolen - Investing.com

...

TipRanks 2d

DexCom price target raised to $95 from $75 at TD Cowen

TD Cowen analyst Joshua Jennings raised the firm’s price target on DexCom (DXCM) to $95 from $75 and keeps a Buy rating on the shares. The firm said the company...

Simply Wall St 2d

Assessing DexCom Valuation After Recent Share Price Momentum And Mixed Growth Signals

Advertisement Why DexCom (DXCM) is on investors’ radar Without a single headline event driving attention, DexCom (DXCM) is drawing interest as investors reass...

Analyst ratings

84%

of 31 ratings

Buy

83.9%

Hold

16.1%

Sell

More DXCM News

TipRanks 3d

Dexcom Earns Buy Rating as CONNECT Trial Strengthens CGM Outlook and Analyst Raises Price Target from $75 to $85

Dexcom, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Anthony Petrone from Mizuho Securities maintained a Buy rating...

TipRanks 3d

DexCom price target raised to $91 from $81 at Raymond James

Raymond James raised the firm’s price target on DexCom (DXCM) to $91 from $81 and keeps a Strong Buy rating on the shares. While acknowledging the high expectat...

Benzinga 3d

Clinical Wins Boost Dexcom Growth Story In Type 2 Diabetes

DexCom Inc. (NASDAQ:DXCM) stock is trading higher on Monday after the diabetes management company reported positive results from its CONNECT randomized controll...

TipRanks 4d

DexCom announces results from CONNECT trial of Dexcom G7

DexCom (DXCM) announced results from the CONNECT randomized controlled trial, demonstrating the use of Dexcom G7 leads to clinically and statistically significa...

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.